Overview

Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Desloratadine